SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-19-006022
Filing Date
2019-09-25
Accepted
2019-09-25 17:31:20
Documents
1
Period of Report
2019-09-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 8716
  Complete submission text file 0000919574-19-006022.txt   11367
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Reporting) CIK: 0001601086 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 191115028

Mailing Address C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 212-231-4932
Armistice Capital Master Fund Ltd. (Reporting) CIK: 0001633584 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 191115027

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address
Boyd Steven (Reporting) CIK: 0001706140 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 191115026